TY - JOUR
T1 - Global Forum of Cancer Surgeons
T2 - Cancer Surgery During the COVID-19 Pandemic: Impact and Lessons Learned
AU - Are, Chandrakanth
AU - Tyler, D.
AU - Howe, J.
AU - Olivares, A.
AU - Nissan, A.
AU - Zippel, D.
AU - Gupta, A.
AU - Savant, D.
AU - D’Ugo, D.
AU - Rubio, I.
AU - Bargallo-Rocha, J. E.
AU - Martinez-Said, H.
AU - Takeuchi, H.
AU - Taketomi, A.
AU - Oliveira, A. F.
AU - Ribeiro, H. S.Castro
AU - Cheema, M. A.
AU - Majid, H. J.
AU - Chen, G.
AU - Roviello, F.
AU - Gronchi, A.
AU - Leon, A.
AU - Lee, W. Y.
AU - Park, D. J.
AU - Park, J.
AU - Auer, R.
AU - Gawad, W. A.
AU - Zaghloul, A.
N1 - Publisher Copyright:
© 2022, Society of Surgical Oncology.
PY - 2022/5
Y1 - 2022/5
N2 - Background: The purpose of this article is to summarize the opinions of the surgical oncology leaders from the Global Forum of Cancer Surgeons (GFCS) about the global impact of COVID-19 pandemic on cancer surgery. Methods: A panel session (virtual) was held at the annual Society of Surgical Oncology 2021 International Conference on Surgical Cancer Care to address the impact of COVID-19 on cancer surgery globally. Following the virtual meeting, a questionnaire was sent to all the leaders to gather additional opinions. The input obtained from all the leaders was collated and analyzed to understand how cancer surgeons from across the world adapted in real-time to the impact of COVID-19 pandemic. Results: The surgical oncology leaders noted that the COVID-19 pandemic led to severe disruptions in surgical cancer care across all domains of clinical care, education, and research. Several new changes/protocols associated with increased costs were implemented to deliver safe care. Leaders also noted that preexisting disparities in care were exacerbated, and the pandemic had a detrimental effect on well-being and financial status. Conclusions: The COVID-19 pandemic has led to severe disruptions in surgical cancer care globally. Leaders of the GFCS opined that new strategies need to be implemented to prepare for any future catastrophic events based on the lessons learned from the current events. The GFCS will embark on developing such a roadmap to ensure that surgical cancer care is preserved in the future regardless of any catastrophic global events.
AB - Background: The purpose of this article is to summarize the opinions of the surgical oncology leaders from the Global Forum of Cancer Surgeons (GFCS) about the global impact of COVID-19 pandemic on cancer surgery. Methods: A panel session (virtual) was held at the annual Society of Surgical Oncology 2021 International Conference on Surgical Cancer Care to address the impact of COVID-19 on cancer surgery globally. Following the virtual meeting, a questionnaire was sent to all the leaders to gather additional opinions. The input obtained from all the leaders was collated and analyzed to understand how cancer surgeons from across the world adapted in real-time to the impact of COVID-19 pandemic. Results: The surgical oncology leaders noted that the COVID-19 pandemic led to severe disruptions in surgical cancer care across all domains of clinical care, education, and research. Several new changes/protocols associated with increased costs were implemented to deliver safe care. Leaders also noted that preexisting disparities in care were exacerbated, and the pandemic had a detrimental effect on well-being and financial status. Conclusions: The COVID-19 pandemic has led to severe disruptions in surgical cancer care globally. Leaders of the GFCS opined that new strategies need to be implemented to prepare for any future catastrophic events based on the lessons learned from the current events. The GFCS will embark on developing such a roadmap to ensure that surgical cancer care is preserved in the future regardless of any catastrophic global events.
UR - http://www.scopus.com/inward/record.url?scp=85125138885&partnerID=8YFLogxK
U2 - 10.1245/s10434-022-11506-3
DO - 10.1245/s10434-022-11506-3
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35211857
AN - SCOPUS:85125138885
SN - 1068-9265
VL - 29
SP - 2773
EP - 2783
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 5
ER -
